公开(公告)号：US11202783B2

公开(公告)日：2021-12-21

申请号：US16631611

申请日：2018-07-20

申请人： CJ Healthcare Corporation

发明人： Hyungjin Jun ,  So Young Ki ,  Keunho Lee ,  Jin Woo Jung ,  Dong Hyun Kim ,  Chi Hye Park ,  Hyoung Rok Bak ,  Shin-Young Ryu ,  Ju Hyun Lee ,  Ho-Youl Lee ,  Won-Hyuk Jung ,  Dong Hyun Ko ,  Seungin Kim ,  Joonseok Byun ,  Jae Ho Yoo ,  Seunghee Ji

IPC分类号： A61K31/554

摘要： The present disclosure relates to a pharmaceutical composition for preventing or treating non-alcoholic fatty liver disease or dyslipidemia comprising an aminoalkylbenzothiazepine derivative or a pharmaceutically acceptable salt thereof as an active ingredient.

公开(公告)号：US20200147101A1

公开(公告)日：2020-05-14

申请号：US16631611

申请日：2018-07-20

申请人： CJ Healthcare Corporation

发明人： Hyungjin Jun ,  So Young Ki ,  Keunho Lee ,  Jin Woo Jung ,  Dong Hyun Kim ,  Chi Hye Park ,  Hyoung Rok Bak ,  Shin-Young Ryu ,  Ju Hyun Lee ,  Ho-Youl Lee ,  Won-Hyuk Jung ,  Dong Hyun Ko ,  Seungin Kim ,  Joonseok Byun ,  Jae Ho Yoo ,  Seunghee Ji

IPC分类号： A61K31/554

摘要： The present disclosure relates to a pharmaceutical composition for preventing or treating non-alcoholic fatty liver disease or dyslipidemia comprising an aminoalkylbenzothiazepine derivative or a pharmaceutically acceptable salt thereof as an active ingredient.